Oncology PracticeLapatinib inferior to trastuzumab for HER2-positive breast cancerMarch 16, 2015Breast Cancer
Oncology PracticeVIDEO: Following breast cancer diagnosis, risk of thyroid cancer risesMarch 11, 2015Breast Cancer
Oncology PracticeSEER: Breast cancer survivors at increased risk of thyroid cancerMarch 11, 2015Breast CancerPatient & Survivor Care
Oncology Practice21-gene recurrence score assay underwent rapid uptake in U.S. breast cancer patientsMarch 5, 2015Breast Cancer
Oncology PracticeTrastuzumab emtansine investigated for early-stage breast cancerFebruary 23, 2015Breast Cancer
Oncology PracticeMore cancer patients surviving longer, but age-based disparities remainFebruary 19, 2015Lung CancerBreast CancerRare DiseasesPatient & Survivor CarePreventive Care
Oncology PracticeDual HER2 targeting benefits OS of patients with advanced breast cancerFebruary 19, 2015Breast Cancer
The Journal of Community and Supportive OncologyPerceptions about participation in cancer clinical trials in New York stateFebruary 18, 2015Patient & Survivor CareBreast Cancer
The Journal of Community and Supportive OncologyJoint breast and colorectal cancer screenings in medically underserved womenFebruary 18, 2015Breast CancerGastroenterologyGastrointestinal Cancer
Oncology PracticeBevacizumab plus ET failed to improve PFS in HER2-negative, HR-positive BCFebruary 17, 2015Breast Cancer
Oncology PracticeCancer mortality lowest in western United StatesFebruary 15, 2015Breast CancerLung Cancer
Oncology PracticeTreatments for metastatic breast cancer expanding but decisions personalizedFebruary 13, 2015Breast Cancer
Oncology PracticeSmoking linked to many ‘new’ causes of deathFebruary 11, 2015Breast CancerGenitourinary CancerPreventive CareGastroenterologyGI OncologyGastrointestinal Cancer
Oncology PracticeStage trumps biology for most small triple-negative breast cancersFebruary 11, 2015Breast Cancer
